Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Lipid droplets can promote drug accumulation and activation.

Dubey R, Stivala CE, Nguyen HQ, Goo YH, Paul A, Carette JE, Trost BM, Rohatgi R.

Nat Chem Biol. 2020 Jan 13. doi: 10.1038/s41589-019-0447-7. [Epub ahead of print]

PMID:
31932720
2.

Cholesterol Acceptors Regulate the Lipidome of Macrophage Foam Cells.

Paul A, Lydic TA, Hogan R, Goo YH.

Int J Mol Sci. 2019 Aug 2;20(15). pii: E3784. doi: 10.3390/ijms20153784.

3.

Lipidomics unveils the complexity of the lipidome in metabolic diseases.

Lydic TA, Goo YH.

Clin Transl Med. 2018 Jan 26;7(1):4. doi: 10.1186/s40169-018-0182-9. Review.

4.
5.

Transcriptional profiling of foam cells in response to hypercholesterolemia.

Goo YH, Yechoor VK, Paul A.

Genom Data. 2016 Jun 20;9:37-9. doi: 10.1016/j.gdata.2016.06.006. eCollection 2016 Sep.

7.

Lipid droplet-associated proteins in atherosclerosis (Review).

Plakkal Ayyappan J, Paul A, Goo YH.

Mol Med Rep. 2016 Jun;13(6):4527-34. doi: 10.3892/mmr.2016.5099. Epub 2016 Apr 11. Review.

8.

Enhanced atheroprotection and lesion remodelling by targeting the foam cell and increasing plasma cholesterol acceptors.

Son SH, Goo YH, Choi M, Saha PK, Oka K, Chan LC, Paul A.

Cardiovasc Res. 2016 Feb 1;109(2):294-304. doi: 10.1093/cvr/cvv241. Epub 2015 Oct 20.

9.

Novel lipid droplet-associated serine hydrolase regulates macrophage cholesterol mobilization.

Goo YH, Son SH, Kreienberg PB, Paul A.

Arterioscler Thromb Vasc Biol. 2014 Feb;34(2):386-96. doi: 10.1161/ATVBAHA.113.302448. Epub 2013 Dec 19.

10.

Perilipin 2 (PLIN2)-deficiency does not increase cholesterol-induced toxicity in macrophages.

Son SH, Goo YH, Chang BH, Paul A.

PLoS One. 2012;7(3):e33063. doi: 10.1371/journal.pone.0033063. Epub 2012 Mar 12.

11.

Identification of MBNL1 and MBNL3 domains required for splicing activation and repression.

Grammatikakis I, Goo YH, Echeverria GV, Cooper TA.

Nucleic Acids Res. 2011 Apr;39(7):2769-80. doi: 10.1093/nar/gkq1155. Epub 2010 Nov 24.

12.

CUGBP2 directly interacts with U2 17S snRNP components and promotes U2 snRNA binding to cardiac troponin T pre-mRNA.

Goo YH, Cooper TA.

Nucleic Acids Res. 2009 Jul;37(13):4275-86. doi: 10.1093/nar/gkp346. Epub 2009 May 14.

13.

Crucial roles for interactions between MLL3/4 and INI1 in nuclear receptor transactivation.

Lee S, Kim DH, Goo YH, Lee YC, Lee SK, Lee JW.

Mol Endocrinol. 2009 May;23(5):610-9. doi: 10.1210/me.2008-0455. Epub 2009 Feb 12.

14.

Interactions between activating signal cointegrator-2 and the tumor suppressor retinoblastoma in androgen receptor transactivation.

Goo YH, Na SY, Zhang H, Xu J, Hong S, Cheong J, Lee SK, Lee JW.

J Biol Chem. 2004 Feb 20;279(8):7131-5. Epub 2003 Nov 25.

15.

Activating signal cointegrator 2 belongs to a novel steady-state complex that contains a subset of trithorax group proteins.

Goo YH, Sohn YC, Kim DH, Kim SW, Kang MJ, Jung DJ, Kwak E, Barlev NA, Berger SL, Chow VT, Roeder RG, Azorsa DO, Meltzer PS, Suh PG, Song EJ, Lee KJ, Lee YC, Lee JW.

Mol Cell Biol. 2003 Jan;23(1):140-9.

16.

Multiple developmental defects derived from impaired recruitment of ASC-2 to nuclear receptors in mice: implication for posterior lenticonus with cataract.

Kim SW, Cheong C, Sohn YC, Goo YH, Oh WJ, Park JH, Joe SY, Kang HS, Kim DK, Kee C, Lee JW, Lee HW.

Mol Cell Biol. 2002 Dec;22(24):8409-14.

Supplemental Content

Loading ...
Support Center